ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010

In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request

November 14, 1986

In Brief: Fischinger, SAIC Win $400 Million Contract

March 3, 1995

In Brief – Control Of Many Cancer Forms By End Of The Century, Frederickson Tells House Committee

April 6, 1979

DCCR Community Oncology Program RFP Now Ready

April 27, 1979

In Brief: ASCO Congratulates Klausner; UCLA Names Gasson Head Of Jonsson Center

August 4, 1995